FMR CORP 13D and 13G filings for Bicara Therapeutics Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-03 09:14 am Purchase | 2025-02-24 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | FMR CORP | 2,803,807 5.200% | 686,719 (+32.44%) | Filing |
| 2025-02-12 09:16 am Sale | 2024-12-31 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | FMR CORP | 2,117,088 3.900% | -378,245 (-15.16%) | Filing |
| 2024-09-18 11:57 am Purchase | 2024-09-18 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | FMR CORP | 2,495,333 5.095% | 2,495,333 (New Position) | Filing |